Making Your Research Program Visible to Industry
Federal research funding has declined sharply. Industry-sponsored trials in cardiometabolic medicine, cardiovascular outcomes, and CNS represent a substantive and growing source of research revenue, and a direct pathway to continuing the science you have already built.
Why TrialBridge
Purpose-built for the shift to industry-funded research
Proprietary sponsor intelligence and opportunity tracking
Network-driven platform that improves with scale
Deep expertise in clinical trials, site selection, and operations
The Ground Has Shifted
NIH funding was never guaranteed, but for decades it was predictable. Research programs could compete for it, plan around it, and build careers on it. That has changed. Grants awarded through peer review are now subject to administrative termination with little notice. The question facing most research leaders is no longer how to grow the NIH portfolio. It is how to build a research enterprise that does not depend on it entirely.ding was never guaranteed, but it was predictable. Now it is neither. The institutions that sustain their research enterprise will be the ones that build a competitive position in industry-sponsored trials — not as a backup plan, but as a durable, parallel source of reven
Industry sponsorship is structurally different
Pharmaceutical sponsors award contracts, not grants. Revenue is milestone-driven and not subject to federal policy reversals. The cardiometabolic, CVOT, and CNS pipelines are generating sustained demand for qualified sites. The barrier is not eligibility. It is competitive readiness.
ADVANTAGES
A smarter pathway to expanding research opportunities, strengthening sponsor relationships and maximizing your existing infrastructure.
Replace Declining Funding
Access a growing and lucrative pipeline of pharmaceutical-sponsored trials to offset reductions in government funding.
Built-In Business Development
TrialBridge functions as your outsourced BD team—delivering opportunities directly to your organization and reducing study startup times.
See Opportunities Earlier
Stay ahead with visibility into sponsor pipelines, therapeutic trends, and upcoming trials.
Achieve More Studies
Leverage warm introductions and qualified leads to increase your study acquisition rate. Instill sponsor confidence for repeat trial placement.
Do More with What You Have
Maximize utilization of your existing research infrastructure and lowering your overhead and increasing revenue without administrative Medicare, Medicaid or insurance costs.
We streamline site onboarding, improve communication and ensure consistent data and compliance tracking.